Category: Oncology/Hematology
Oncology/Hematology market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Chronic Lymphocytic Leukemia
The 2025-2030 World Outlook for Chronic Lymphocytic Leukemia This study covers the world outlook for chronic lymphocytic leukemia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Lung Cancer Screening Software
The 2025-2030 World Outlook for Lung Cancer Screening Software This study covers the world outlook for lung cancer screening software across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Hormone Therapy for Prostate Cancer Therapeutics
The 2025-2030 World Outlook for Hormone Therapy for Prostate Cancer Therapeutics This study covers the world outlook for hormone therapy for prostate cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More
-
The 2025-2030 World Outlook for NDDS in Cancer Therapies
The 2025-2030 World Outlook for NDDS in Cancer Therapies This study covers the world outlook for NDDS in cancer therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Cancer Profiling Technologies
The 2025-2030 World Outlook for Cancer Profiling Technologies This study covers the world outlook for cancer profiling technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Cancer Supportive Care Therapeutics
The 2025-2030 World Outlook for Cancer Supportive Care Therapeutics This study covers the world outlook for cancer supportive care therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Cancer Therapies
The 2025-2030 World Outlook for Cancer Therapies This study covers the world outlook for cancer therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Cancer Tumor Profiling
The 2025-2030 World Outlook for Cancer Tumor Profiling This study covers the world outlook for cancer tumor profiling across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Drugs
The 2025-2030 World Outlook for Breast Cancer Drugs This study covers the world outlook for breast cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Treatments
The 2025-2030 World Outlook for Breast Cancer Treatments This study covers the world outlook for breast cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Progestogens for Cancer Cachexia
The 2025-2030 World Outlook for Progestogens for Cancer Cachexia This study covers the world outlook for progestogens for cancer cachexia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Prostate Cancer Therapeutics
The 2025-2030 World Outlook for Prostate Cancer Therapeutics This study covers the world outlook for prostate cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Prostate Cancers
The 2025-2030 World Outlook for Prostate Cancers This study covers the world outlook for prostate cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for In-Vitro Colorectal Cancer Screening Tests
The 2025-2030 World Outlook for In-Vitro Colorectal Cancer Screening Tests This study covers the world outlook for in-vitro colorectal cancer screening tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Urological Cancers
The 2025-2030 World Outlook for Urological Cancers This study covers the world outlook for urological cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Drugs
The 2025-2030 World Outlook for Colorectal Cancer Drugs This study covers the world outlook for colorectal cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Orphan Cancer Drugs
The 2025-2030 World Outlook for Orphan Cancer Drugs This study covers the world outlook for orphan cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for NDDS for Cancer Therapies
The 2025-2030 World Outlook for NDDS for Cancer Therapies This study covers the world outlook for NDDS for cancer therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Neuroendocrine Tumors
The 2025-2030 World Outlook for Neuroendocrine Tumors This study covers the world outlook for neuroendocrine tumors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Oncology Molecular Diagnostics for Breast Cancers
The 2025-2030 World Outlook for Oncology Molecular Diagnostics for Breast Cancers This study covers the world outlook for oncology molecular diagnostics for breast cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earning ... Read More
-
The 2025-2030 World Outlook for Immune-Oncology Treatments
The 2025-2030 World Outlook for Immune-Oncology Treatments This study covers the world outlook for immune-oncology treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Immuno Oncology Assays
The 2025-2030 World Outlook for Immuno Oncology Assays This study covers the world outlook for immuno oncology assays across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Novel Drug Delivery Systems in Cancer Therapies
The 2025-2030 World Outlook for Novel Drug Delivery Systems in Cancer Therapies This study covers the world outlook for novel drug delivery systems in cancer therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2025-2030 World Outlook for Alpha Emitters for Melanoma
The 2025-2030 World Outlook for Alpha Emitters for Melanoma This study covers the world outlook for alpha emitters for melanoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Biological Cancer Treatments
The 2025-2030 World Outlook for Biological Cancer Treatments This study covers the world outlook for biological cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
Research Assistance
